Genetically engineered lymphocytes and adoptive cell therapy: cancer immunotherapy’s smart bombs

被引:0
作者
S K Libutti
机构
[1] Editor-in-Chief Cancer Gene Therapy,
来源
Cancer Gene Therapy | 2015年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:63 / 63
相关论文
共 50 条
  • [21] CANCER IMMUNOTHERAPY: CHECKPOINT INHIBITORS, ADOPTIVE CELL THERAPY, AND BEYOND
    Blackman, Samuel C.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S12 - S12
  • [22] Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
    Yee C.
    Journal of Translational Medicine, 3 (1)
  • [23] Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy
    Pan, Yuanwei
    Wu, Xianjia
    Liu, Lujie
    Zhao, Chenchen
    Zhang, Jing
    Yang, Shengren
    Pan, Pan
    Huang, Qinqin
    Zhao, Xing-Zhong
    Tian, Rui
    Rao, Lang
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (13)
  • [24] Genetically engineered T cells for cancer immunotherapy
    Dan Li
    Xue Li
    Wei-Lin Zhou
    Yong Huang
    Xiao Liang
    Lin Jiang
    Xiao Yang
    Jie Sun
    Zonghai Li
    Wei-Dong Han
    Wei Wang
    Signal Transduction and Targeted Therapy, 4
  • [25] Genetically engineered T cells for cancer immunotherapy
    Li, Dan
    Li, Xue
    Zhou, Wei-Lin
    Huang, Yong
    Liang, Xiao
    Jiang, Lin
    Yang, Xiao
    Sun, Jie
    Li, Zonghai
    Han, Wei-Dong
    Wang, Wei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [26] Smart CARs engineered for cancer immunotherapy
    Priceman, Saul J.
    Forman, Stephen J.
    Brown, Christine E.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (06) : 466 - 474
  • [28] ACTIVATION OF T-LYMPHOCYTES FOR THE ADOPTIVE IMMUNOTHERAPY OF CANCER
    SUSSMAN, JJ
    SHU, S
    SONDAK, VK
    CHANG, AE
    ANNALS OF SURGICAL ONCOLOGY, 1994, 1 (04) : 296 - 306
  • [30] Chimeric Antigen Receptor (CAR) T-cell Therapy: A New Genetically Engineered Method of Immunotherapy for Cancer
    Singh, Arun Kumar
    Malviya, Rishabha
    Singh, Amrita
    Sundram, Sonali
    Mishra, Sudhanshu
    CURRENT CANCER DRUG TARGETS, 2023, 23 (03) : 199 - 210